Blue Water Acquisition Corp. IV

Research Blue Water Acquisition Corp. IV (BWIV) on Bullrun: market cap USD 177.23M, P/E 268.3. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is USD 177.23M; P/E is 268.3.

Peer valuation comparison

Latest P/E is 268.28x versus a Financial Services sector median of 13.41x (1900.6% above).

Latest P/E is 268.28x versus a United States median of 23.75x (1029.8% above).

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-10-12USD 177.23M268.3n/an/a

About Blue Water Acquisition Corp. IV

Blue Water Acquisition Corp. IV does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology, healthcare, and technology industries. The company was incorporated in 2025 and is based in Greenwich, Connecticut.

Related stock research

United States stocks United States Financial Services stocks A-Z stock index

Other Financial Services stocks

Armada Acquisition Corp. III (AACI) Abony Acquisition Corp. I (AACO) Apogee Acquisition Corp (AACP) Averin Capital Acquisition Corp. (ACAA) ACP Holdings Acquisition Corp. (ACGC) American Exceptionalism Acquisition Corp A - Class A (AEXA) Aimei Health Technology Co Ltd (AFJK) AI Infrastructure Acquisition Corp Class A (AIIA) Alchemy Investments Acquisition Corp 1 - Class A (ALCY) Aldel Financial II Inc (ALDF) Centurion Acquisition Corp - Class A (ALF) Calisa Acquisition Corp (ALIS)

Frequently asked questions

What is Blue Water Acquisition Corp. IV's market cap?

Blue Water Acquisition Corp. IV's market capitalization is USD 177.23M.

What is Blue Water Acquisition Corp. IV's P/E ratio?

Blue Water Acquisition Corp. IV's price-to-earnings (P/E) ratio is 268.3.

What does Blue Water Acquisition Corp. IV do?

Blue Water Acquisition Corp. IV does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology, healthcare, and technology industries. The company was incorporated in 2025 and is based in Greenwich, Connecticut.